Percutaneous coronary intervention fractional flow reserve: Difference between revisions
Jump to navigation
Jump to search
/* 2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention: Fractional Flow Reserve{{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, La... |
/* 2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention: Fractional Flow Reserve{{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, La... |
||
| Line 4: | Line 4: | ||
==2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention: Fractional Flow Reserve<ref name="pmid22070837">{{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH |title=2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions |journal=[[Journal of the American College of Cardiology]] |volume=58 |issue=24 |pages=2550–83 |year=2011 |month=December|pmid=22070837|doi=10.1016/j.jacc.2011.08.006|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(11)02875-0|accessdate=2011-12-08|url=http://content.onlinejacc.org/cgi/reprint/58/24/2550.pdf|PDF}}</ref> (DO NOT EDIT)== | ==2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention: Fractional Flow Reserve<ref name="pmid22070837">{{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH |title=2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions |journal=[[Journal of the American College of Cardiology]] |volume=58 |issue=24 |pages=2550–83 |year=2011 |month=December|pmid=22070837|doi=10.1016/j.jacc.2011.08.006|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(11)02875-0|accessdate=2011-12-08|url=http://content.onlinejacc.org/cgi/reprint/58/24/2550.pdf|PDF}}</ref> (DO NOT EDIT)== | ||
{| class="wikitable" | |||
|- | |||
| colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (NO BENEFIT) | |||
|- | |||
| bgcolor="LightCoral"|<nowiki>"</nowiki>'''1.''' IVUS for routine lesion assessment is not recommended when revascularization with PCI or CABG is not being contemplated.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | |||
|} | |||
{|class="wikitable" | {|class="wikitable" | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | | colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' [[Fractional flow reserve]] is reasonable to assess angiographic intermediate coronary lesions (50% to 70% diameter [[stenosis]]) and can be useful for guiding [[Chronic stable angina revascularization|revascularization]] decisions in patients with [[Chronic stable angina|Sudden ischemic heart disease (SIHD)]].<ref name="pmid19144937">{{cite journal |author=Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF |title=Fractional flow reserve versus angiography for guiding percutaneous coronary intervention |journal=[[The New England Journal of Medicine]] |volume=360|issue=3 |pages=213–24 |year=2009 |month=January |pmid=19144937 |doi=10.1056/NEJMoa0807611|url=http://dx.doi.org/10.1056/NEJMoa0807611 |accessdate=2011-12-09}}</ref><ref name="pmid19786633">{{cite journal |author=Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno G, Nelis O, Bartunek J, Vanderheyden M, Wyffels E, Barbato E, Heyndrickx GR, Wijns W, De Bruyne B |title=Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis |journal=[[Circulation]]|volume=120 |issue=15 |pages=1505–12 |year=2009 |month=October |pmid=19786633|doi=10.1161/CIRCULATIONAHA.109.850073 |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=19786633 |accessdate=2011-12-09}}</ref><ref name="pmid17531660">{{cite journal|author=Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van't Veer M, Bär F, Hoorntje J, Koolen J, Wijns W, de Bruyne B |title=Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study |journal=[[Journal of the American College of Cardiology]] |volume=49 |issue=21 |pages=2105–11 |year=2007 |month=May |pmid=17531660|doi=10.1016/j.jacc.2007.01.087|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(07)00911-4|accessdate=2011-12-09}}</ref><ref name="pmid20537493">{{cite journal |author=Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, van't Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, De Bruyne B |title=Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study |journal=[[Journal of the American College of Cardiology]] |volume=56 |issue=3 |pages=177–84|year=2010 |month=July |pmid=20537493 |doi=10.1016/j.jacc.2010.04.012|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(10)01602-5|accessdate=2011-12-09}}</ref><ref name="pmid20579537">{{cite journal |author=Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, Maccarthy PA, Van't Veer M, Pijls NH|title=Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation |journal=[[Journal of the American College of Cardiology]] |volume=55 |issue=25 |pages=2816–21 |year=2010 |month=June|pmid=20579537 |doi=10.1016/j.jacc.2009.11.096|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(10)01439-7|accessdate=2011-12-09}}</ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''<nowiki>"</nowiki> | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' [[Fractional flow reserve]] is reasonable to assess angiographic intermediate coronary lesions (50% to 70% diameter [[stenosis]]) and can be useful for guiding [[Chronic stable angina revascularization|revascularization]] decisions in patients with [[Chronic stable angina|Sudden ischemic heart disease (SIHD)]].<ref name="pmid19144937">{{cite journal |author=Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF |title=Fractional flow reserve versus angiography for guiding percutaneous coronary intervention |journal=[[The New England Journal of Medicine]] |volume=360|issue=3 |pages=213–24 |year=2009 |month=January |pmid=19144937 |doi=10.1056/NEJMoa0807611|url=http://dx.doi.org/10.1056/NEJMoa0807611 |accessdate=2011-12-09}}</ref><ref name="pmid19786633">{{cite journal |author=Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno G, Nelis O, Bartunek J, Vanderheyden M, Wyffels E, Barbato E, Heyndrickx GR, Wijns W, De Bruyne B |title=Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis |journal=[[Circulation]]|volume=120 |issue=15 |pages=1505–12 |year=2009 |month=October |pmid=19786633|doi=10.1161/CIRCULATIONAHA.109.850073 |url=http://circ.ahajournals.org/cgi/pmidlookup?view=long&pmid=19786633 |accessdate=2011-12-09}}</ref><ref name="pmid17531660">{{cite journal|author=Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van't Veer M, Bär F, Hoorntje J, Koolen J, Wijns W, de Bruyne B |title=Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study |journal=[[Journal of the American College of Cardiology]] |volume=49 |issue=21 |pages=2105–11 |year=2007 |month=May |pmid=17531660|doi=10.1016/j.jacc.2007.01.087|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(07)00911-4|accessdate=2011-12-09}}</ref><ref name="pmid20537493">{{cite journal |author=Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, van't Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, De Bruyne B |title=Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study |journal=[[Journal of the American College of Cardiology]] |volume=56 |issue=3 |pages=177–84|year=2010 |month=July |pmid=20537493 |doi=10.1016/j.jacc.2010.04.012|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(10)01602-5|accessdate=2011-12-09}}</ref><ref name="pmid20579537">{{cite journal |author=Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, Maccarthy PA, Van't Veer M, Pijls NH|title=Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation |journal=[[Journal of the American College of Cardiology]] |volume=55 |issue=25 |pages=2816–21 |year=2010 |month=June|pmid=20579537 |doi=10.1016/j.jacc.2009.11.096|url=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(10)01439-7|accessdate=2011-12-09}}</ref> ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: A]])''<nowiki>"</nowiki> | ||
| Line 16: | Line 24: | ||
|- | |- | ||
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | | colspan="1" style="text-align:center; background:LemonChiffon"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' IVUS is reasonable for the assessment of angiographically indeterminant left main CAD.248–250 ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' IVUS is reasonable for the assessment of angiographically indeterminant left main CAD.248–250 ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.''' IVUS and coronary angiography are reasonable 4 to 6 weeks and 1 year after cardiac transplantation to exclude donor CAD, detect rapidly progressive cardiac allograft vasculopathy, and provide prognostic information. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.''' IVUS and coronary angiography are reasonable 4 to 6 weeks and 1 year after cardiac transplantation to exclude donor CAD, detect rapidly progressive cardiac allograft vasculopathy, and provide prognostic information. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''3.''' IVUS is reasonable to determine the mechanism of stent restenosis.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''3.''' IVUS is reasonable to determine the mechanism of stent restenosis.''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki> | ||
| Line 38: | Line 44: | ||
|- | |- | ||
|bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''3.'''IVUS may be reasonable to determine the mechanism of stent thrombosis. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | |bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''3.'''IVUS may be reasonable to determine the mechanism of stent thrombosis. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
|} | |} | ||
Revision as of 17:06, 30 October 2012
|
Percutaneous Coronary Intervention Guidelines Microchapters |
|
PCI Approaches: |
|---|
|
CAD Revascularization: |
|
Pre-procedural Considerations: |
|
Procedural Considerations: |
|
|
|
|
|
|
|
|
|
|
Post-Procedural Considerations: |
|
Quality and Performance Considerations: |
|
Percutaneous coronary intervention fractional flow reserve On the Web |
|
American Roentgen Ray Society Images of Percutaneous coronary intervention fractional flow reserve |
|
FDA on Percutaneous coronary intervention fractional flow reserve |
|
CDC on Percutaneous coronary intervention fractional flow reserve |
|
Percutaneous coronary intervention fractional flow reserve in the news |
|
Blogs on Percutaneous coronary intervention fractional flow reserve |
|
Directions to Hospitals Treating Percutaneous Coronary Intervention |
|
Risk calculators and risk factors for Percutaneous coronary intervention fractional flow reserve |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
2011 ACCF/AHA/SCAI Guidelines for Percutaneous Coronary Intervention: Fractional Flow Reserve[1] (DO NOT EDIT)
| Class III (NO BENEFIT) |
| "1. IVUS for routine lesion assessment is not recommended when revascularization with PCI or CABG is not being contemplated.(Level of Evidence: C)" |
| Class IIa |
| "1. Fractional flow reserve is reasonable to assess angiographic intermediate coronary lesions (50% to 70% diameter stenosis) and can be useful for guiding revascularization decisions in patients with Sudden ischemic heart disease (SIHD).[2][3][4][5][6] (Level of Evidence: A)" |
| Class IIa |
| "1. IVUS is reasonable for the assessment of angiographically indeterminant left main CAD.248–250 (Level of Evidence: B)" |
| "2. IVUS and coronary angiography are reasonable 4 to 6 weeks and 1 year after cardiac transplantation to exclude donor CAD, detect rapidly progressive cardiac allograft vasculopathy, and provide prognostic information. (Level of Evidence: B)" |
| "3. IVUS is reasonable to determine the mechanism of stent restenosis.(Level of Evidence: C)" |
| Class IIa |
| "1.IVUS may be reasonable for the assessment of non–left main coronary arteries with angiographically intermediate coronary stenoses (50% to 70% diameter stenosis). (Level of Evidence: B)" |
| "2.IVUS may be considered for guidance of coronary stent implantation, particularly in cases of left main coronary artery stenting.(Level of Evidence: B)" |
| "3.IVUS may be reasonable to determine the mechanism of stent thrombosis. (Level of Evidence: B)" |
2005 ACC/AHA/SCAI Guidelines for Percutaneous Coronary Intervention: Coronary Artery Pressure and Flow:Use of Fractional Flow Reserve and Coronary Vasodilatory Reserve[7](DO NOT EDIT)
| Class III |
| "1.Routine assessment with intracoronary physiologic measurements such as Doppler ultrasound or fractional flow reserve to assess the severity of angiographic disease in patients with a positive, unequivocal noninvasive functional study is not recommended.(Level of Evidence: C) " |
| Class IIa |
| "1.It is reasonable to use intracoronary physiologic measurements (Doppler ultrasound, fractional flow reserve) in the assessment of the effects of intermediate coronary stenoses (30% to 70% luminal narrowing) in patients with anginal symptoms. Coronary pressure or Dopplervelocimetry may also be useful as an alternative to performing noninvasive functional testing (e.g., when the functional study is absent or ambiguous) to determine whether an intervention is warranted.(Level of Evidence: B) " |
| Class IIb |
| "1.Intracoronary physiologic measurements may be considered for the evaluation of the success of PCI in restoring flow reserve and to predict the risk of restenosis. (Level of Evidence: C) " |
| "2. Intracoronary physiologic measurements may be considered for the evaluation of patients with anginal symptoms without an apparent angiographic culprit lesion. (Level of Evidence: C) " |
References
- ↑ Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Ting HH (2011). "2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions" (PDF). Journal of the American College of Cardiology. 58 (24): 2550–83. doi:10.1016/j.jacc.2011.08.006. PMID 22070837. Retrieved 2011-12-08. Text "PDF" ignored (help); Unknown parameter
|month=ignored (help) - ↑ Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF (2009). "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention". The New England Journal of Medicine. 360 (3): 213–24. doi:10.1056/NEJMoa0807611. PMID 19144937. Retrieved 2011-12-09. Unknown parameter
|month=ignored (help) - ↑ Hamilos M, Muller O, Cuisset T, Ntalianis A, Chlouverakis G, Sarno G, Nelis O, Bartunek J, Vanderheyden M, Wyffels E, Barbato E, Heyndrickx GR, Wijns W, De Bruyne B (2009). "Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis". Circulation. 120 (15): 1505–12. doi:10.1161/CIRCULATIONAHA.109.850073. PMID 19786633. Retrieved 2011-12-09. Unknown parameter
|month=ignored (help) - ↑ Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van't Veer M, Bär F, Hoorntje J, Koolen J, Wijns W, de Bruyne B (2007). "Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study". Journal of the American College of Cardiology. 49 (21): 2105–11. doi:10.1016/j.jacc.2007.01.087. PMID 17531660. Retrieved 2011-12-09. Unknown parameter
|month=ignored (help) - ↑ Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, van't Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, De Bruyne B (2010). "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study". Journal of the American College of Cardiology. 56 (3): 177–84. doi:10.1016/j.jacc.2010.04.012. PMID 20537493. Retrieved 2011-12-09. Unknown parameter
|month=ignored (help) - ↑ Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, Maccarthy PA, Van't Veer M, Pijls NH (2010). "Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation". Journal of the American College of Cardiology. 55 (25): 2816–21. doi:10.1016/j.jacc.2009.11.096. PMID 20579537. Retrieved 2011-12-09. Unknown parameter
|month=ignored (help) - ↑ Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB; et al. (2006). "ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention)". Circulation. 113 (7): e166–286. doi:10.1161/CIRCULATIONAHA.106.173220. PMID 16490830.